Shell Asset Management CO Eli Lilly & CO Transaction History

Shell Asset Management CO

$2.27 Billion
Q3 2024

A detailed history of Shell Asset Management CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Shell Asset Management CO holds 38,123 shares of LLY stock, worth $30 Million. This represents 1.49% of its overall portfolio holdings.

Number of Shares

38,123

Previous 41,172 7.41%

Holding current value

$30 Million

Previous $37.3 Million 9.39%

% of portfolio

1.49%

Previous 1.7%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$772.14 - $960.02 $2.35 Million - $2.93 Million	-3,049 Reduced 7.41%	38,123 $33.8 Million
Q1 2024 Jul 31, 2024	SELL	$592.2 - $792.28 $1.79 Million - $2.4 Million	-3,026 Reduced 6.85%	41,172 $37.3 Million
Q1 2024 May 14, 2024	SELL	$592.2 - $792.28 $537,717 - $719,390	-908 Reduced 2.01%	44,198 $34.4 Million
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $6.55 Million - $7.72 Million	-12,465 Reduced 21.65%	45,106 $26.3 Million
Q3 2023 Nov 08, 2023	SELL	$434.7 - $599.3 $519,031 - $715,564	-1,194 Reduced 2.03%	57,571 $30.9 Million
Q2 2023 Jul 28, 2023	BUY	$350.74 - $468.98 $1.9 Million - $2.54 Million	5,419 Added 10.16%	58,765 $27.6 Million
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $1.71 Million - $2.01 Million	5,498 Added 11.49%	53,346 $18.3 Million
Q4 2022 Feb 07, 2023	SELL	$321.55 - $374.67 $3.06 Million - $3.57 Million	-9,516 Reduced 16.59%	47,848 $17.5 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $3.72 Million - $4.24 Million	-12,561 Reduced 17.96%	57,364 $18.5 Million
Q2 2022 Aug 09, 2022	BUY	$278.73 - $327.27 $2.93 Million - $3.44 Million	10,501 Added 17.67%	69,925 $22.7 Million
Q1 2022 May 04, 2022	SELL	$234.69 - $291.66 $846,526 - $1.05 Million	-3,607 Reduced 5.72%	59,424 $17 Million
Q4 2021 Feb 09, 2022	SELL	$224.85 - $279.04 $1.88 Million - $2.33 Million	-8,356 Reduced 11.71%	63,031 $17.4 Million
Q3 2021 Nov 04, 2021	SELL	$221.6 - $272.71 $4 Million - $4.92 Million	-18,057 Reduced 20.19%	71,387 $16.5 Million
Q2 2021 Aug 12, 2021	SELL	$180.55 - $233.54 $1.74 Million - $2.24 Million	-9,612 Reduced 9.7%	89,444 $20.5 Million
Q1 2021 May 10, 2021	SELL	$164.32 - $212.72 $3.66 Million - $4.74 Million	-22,304 Reduced 18.38%	99,056 $18.5 Million
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $551,715 - $730,052	-4,229 Reduced 3.37%	121,360 $20.5 Million
Q3 2020 Nov 13, 2020	SELL	$146.22 - $169.13 $91,826 - $106,213	-628 Reduced 0.5%	125,589 $18.6 Million
Q2 2020 Aug 10, 2020	BUY	$136.42 - $164.18 $1.48 Million - $1.78 Million	10,848 Added 9.4%	126,217 $20.7 Million
Q1 2020 May 11, 2020	SELL	$119.05 - $147.35 $308,815 - $382,225	-2,594 Reduced 2.2%	115,369 $16 Million
Q4 2019 Feb 13, 2020	SELL	$106.92 - $132.43 $1.53 Million - $1.9 Million	-14,341 Reduced 10.84%	117,963 $15.5 Million
Q3 2019 Nov 12, 2019	SELL	$106.79 - $116.16 $744,219 - $809,519	-6,969 Reduced 5.0%	132,304 $14.8 Million
Q2 2019 Aug 12, 2019	SELL	$110.79 - $129.32 $879,118 - $1.03 Million	-7,935 Reduced 5.39%	139,273 $15.4 Million
Q1 2019 May 09, 2019	SELL	$111.31 - $131.02 $5.43 Million - $6.4 Million	-48,816 Reduced 24.9%	147,208 $19.1 Million
Q4 2018 Feb 13, 2019	SELL	$105.9 - $118.64 $3.3 Million - $3.69 Million	-31,131 Reduced 13.7%	196,024 $22.7 Million
Q3 2018 Nov 13, 2018	SELL	$85.86 - $107.31 $1.31 Million - $1.64 Million	-15,245 Reduced 6.29%	227,155 $24.4 Million
Q2 2018 Aug 10, 2018	SELL	$75.7 - $86.88 $3.84 Million - $4.4 Million	-50,696 Reduced 17.3%	242,400 $20.7 Million
Q1 2018 May 14, 2018	BUY	$74.21 - $87.6 $263,742 - $311,330	3,554 Added 1.23%	293,096 $22.7 Million
Q4 2017 Feb 09, 2018	BUY	$81.94 - $87.89 $41,461 - $44,472	506 Added 0.18%	289,542 $24.5 Million
Q3 2017 Oct 20, 2017	SELL	$77.07 - $85.54 $7.91 Million - $8.78 Million	-102,603 Reduced 26.2%	289,036 $24.7 Million
Q3 2017 Oct 18, 2017	BUY	$77.07 - $85.54 $30.2 Million - $33.5 Million	391,639	391,639 $25.4 Million

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $749B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Shell Asset Management CO with notifications on news.

Account

Shell Asset Management CO Eli Lilly & CO Transaction History